Riskpilot← Back to searchSign inGet full accessAPO PHARM ApS
APSActiveCVR 15226072Ringstedvej 173Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19919 employees
Revenue 2025
DKK 1,5M
-3% vs 2024
EBITDA margin
10.4%
-24% vs 2024
Equity ratio
18.4%
Financial strength
Net profit 2025
DKK 27K
-78% vs 2024
| Revenue | DKK 1,5M | -3% |
| EBITDA | DKK 154K | -24% |
| Net profit | DKK 27K | -78% |
| Total assets | DKK 1,8M | +9% |
| Equity | DKK 332K | -34% |
| Employees | 9 | — |
Legal name
APO PHARM ApS
CVR number
15226072
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. juni 1991
Share capital
DKK 125.000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren, eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive handel og dermed tilknyttede aktiviteter.
Address
Ringstedvej 173
Phone
+4536410151
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 774 | 783 | 1.032 | 945 | 939 | 1.021 | 1.166 | 1.799 | 2.124 | 1.673 | 1.277 | 1.385 | 1.522 | 1.481 |
| Staff expenses | -888 | -841 | -1.002 | -923 | -853 | -969 | -1.060 | -836 | -1.267 | -982 | -993 | -1.010 | -1.320 | -1.327 |
| EBITDA | -114 | -58 | 30 | 22 | 86 | 52 | 106 | 963 | 858 | 690 | 286 | 372 | 202 | 154 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -1 | -3 | -3 | -3 | -3 | -3 | -0 | -21 | -42 | -42 |
| EBIT | -114 | -58 | 30 | 22 | 85 | 49 | 103 | 960 | 854 | 688 | 286 | 351 | 160 | 112 |
| Net financials | -19 | -106 | -42 | -19 | -14 | 18 | -17 | 0 | 19 | 39 | 49 | 17 | 2 | -76 |
| Profit before tax | -68 | -88 | -12 | 3 | 71 | 67 | 86 | 960 | 873 | 727 | 334 | 370 | 162 | 36 |
| Tax | 32 | 38 | 8 | 1 | 17 | 15 | 20 | 212 | 195 | 161 | 80 | 77 | 41 | 9 |
| Net profit | -101 | -126 | -20 | 2 | 54 | 52 | 66 | 748 | 678 | 566 | 254 | 293 | 121 | 27 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 872 | 833 | 828 | 764 | 862 | 931 | 1.278 | 2.169 | 2.338 | 2.529 | 2.169 | 1.691 | 1.659 | 1.810 |
| Equity | 317 | 191 | 171 | 173 | 227 | 279 | 345 | 1.093 | 1.072 | 1.038 | 691 | 684 | 505 | 332 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 183 | 231 | 201 | 114 | 120 | 82 | 880 |
| Short-term debt | 555 | 642 | 657 | 591 | 635 | 652 | 933 | 893 | 1.036 | 1.291 | 1.364 | 887 | 1.071 | 598 |
| Total debt | 555 | 642 | 657 | 591 | 635 | 652 | 933 | 1.076 | 1.266 | 1.492 | 1.478 | 1.007 | 1.153 | 1.478 |
EBITDA margin
10.4%
This company
15.8%
Market median
-34% vs market
20122025
Equity ratio
18.4%
This company
38.2%
Market median
-52% vs market
20122025
Return on equity
8.1%
This company
18.4%
Market median
-56% vs market
20122025
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20122025
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20122025
Debt / equity
4.45×
This company
0.62×
Market median
-618% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SB Founder | Founder | 1991 | — | — |
HL Management | Management | 2007 | — | — |
PK Audit | Audit | 1991 | — | — |
NE Founder | Founder | 1991 | — | — |
DN Founder | Founder | 1991 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2014 | — | — | |
| Chairman | 2011 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
VESTI LARSEN ApS | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
VESTI LARSEN ApS
APO PHARM ApS Board members of APO PHARM ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Brogreen | Founder | 0 companies |
| Helge Larsen | Management | 0 companies |
| Palle Konradsen | Audit | 0 companies |
| Niels Engelhardt | Founder | 0 companies |
| Dorthe Ninna Larsen | Founder | 0 companies |
| Hanne Vesti Petersen | Board of Directors | 0 companies |
| Kresten Mikael Valdal | Chairman | 0 companies |
| Marthine Overgaard Bertelsen | Board of Directors | 0 companies |
| Vagn Alfred Ohlsen | Chairman | 0 companies |